Literature DB >> 12484709

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States.

George Ostapowicz1, Robert J Fontana, Frank V Schiødt, Anne Larson, Timothy J Davern, Steven H B Han, Timothy M McCashland, A Obaid Shakil, J Eileen Hay, Linda Hynan, Jeffrey S Crippin, Andres T Blei, Grace Samuel, Joan Reisch, William M Lee.   

Abstract

BACKGROUND: Because acute liver failure is rare, related data have been sparse. Studies have suggested that viral hepatitis is the most common underlying cause of this condition.
OBJECTIVE: To describe the clinical features, presumed causes, and short-term outcomes of acute liver failure.
DESIGN: Prospective cohort study.
SETTING: 17 tertiary care centers participating in the U.S. Acute Liver Failure Study Group. PATIENTS: 308 consecutive patients with acute liver failure, admitted over a 41-month period. MEASUREMENTS: Detailed clinical and laboratory data collected during hospitalization, including outcome 3 weeks after study admission.
RESULTS: 73% of patients were women; median age was 38 years. Acetaminophen overdose was the most common apparent cause of acute liver failure, accounting for 39% of cases. Idiosyncratic drug reactions were the presumptive cause in 13% of cases, viral hepatitis A and B combined were implicated in 12% of cases, and 17% of cases were of indeterminate cause. Overall patient survival at 3 weeks was 67%. Twenty-nine percent of patients had liver transplantation, and 43% survived without transplantation. Short-term transplant-free survival varied greatly, from 68% for patients with acetaminophen-related liver failure to 25% and 17% for those with other drug reactions and liver failure of indeterminate cause, respectively. Coma grade at admission appeared to be associated with outcome, but age and symptom duration did not.
CONCLUSIONS: Acetaminophen overdose and idiosyncratic drug reactions have replaced viral hepatitis as the most frequent apparent causes of acute liver failure. Apparent cause and coma grade at admission were associated with outcome. Although transplantation may improve patient survival, it was unavailable or unnecessary for most patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484709     DOI: 10.7326/0003-4819-137-12-200212170-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  514 in total

1.  Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.

Authors:  Taru Kantola; Suvi Mäklin; Anna-Maria Koivusalo; Pirjo Räsänen; Anne Rissanen; Risto Roine; Harri Sintonen; Krister Höckerstedt; Helena Isoniemi
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations.

Authors:  Pavel Strnad; Qin Zhou; Shinichiro Hanada; Laura C Lazzeroni; Bi Hui Zhong; Phillip So; Timothy J Davern; William M Lee; M Bishr Omary
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

Review 3.  Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  Toxicol Sci       Date:  2010-06-10       Impact factor: 4.849

4.  Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure.

Authors:  Niraj Khandelwal; Laura P James; Corron Sanders; Anne M Larson; William M Lee
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

5.  Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.

Authors:  Marwan Ghabril; Robert Fontana; Don Rockey; Gu Jiezhun; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

6.  Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Authors:  Nathalie H Urrunaga; Laurence S Magder; Matthew R Weir; Don C Rockey; Ayse L Mindikoglu
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

7.  Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure.

Authors:  Sundeep Singh; Linda S Hynan; William M Lee
Journal:  Dig Dis Sci       Date:  2013-01-17       Impact factor: 3.199

Review 8.  Mechanisms of drug-induced liver injury.

Authors:  Michael P Holt; Cynthia Ju
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 9.  [Morphology of drug induced liver damage].

Authors:  H-U Kasper; U Drebber; I Hirsch; H P Dienes
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

10.  Adult-to-adult living donor liver transplantation for acute liver failure in China.

Authors:  Ding Yuan; Fei Liu; Yong-Gang Wei; Bo Li; Lv-Nan Yan; Tian-Fu Wen; Ji-Chun Zhao; Yong Zeng; Ke-Fei Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.